Dr. Andreas Vente

Managing Director MerLion Pharmaceuticals GmbH
Toxicology
MerLion Pharmaceuticals
Singapore

Scientist Toxicology
Biography

  Dr. Andreas Vente joined MerLion in 2006 in conjunction with the acquisition of Combinature Biopharm AG. Before becoming Managing Director of MerLion’s drug development subsidiary in Berlin in 2009, he was head of project management and non-clinical development. For Combinature Biopharm AG he worked as COO and in various management positions. Between 1998 and 2000 he was the Head of the Laboratories of the RZPD German Resource Center for Genome Research GmbH. Earlier, he worked as a postdoctoral fellow at the ETH, Zürich and the German Cancer Research Center, Heidelberg. Dr. Vente obtained an MSc in Biology from the University of Cologne, Germany, in 1992 and a PhD at the Max Planck Institute for Plant Breeding Research, Cologne, in 1996.

Research Intrest

  Drug development, non-clinical development, Plant Breeding Research